Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Predictive Oncology Inc
NASDAQ:POAI
|
US |
|
Loctek Ergonomic Technology Corp
SZSE:300729
|
CN |
Ahn-Gook Pharmaceutical Co Ltd
Total Equity
Ahn-Gook Pharmaceutical Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
Total Equity
₩165.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
Yuhan Corp
KRX:000100
|
Total Equity
₩2.3T
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Equity
₩813B
|
CAGR 3-Years
37%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Equity
₩1.2T
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Equity
₩276B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Equity
₩212.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Ahn-Gook Pharmaceutical Co Ltd
Glance View
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.
See Also
What is Ahn-Gook Pharmaceutical Co Ltd's Total Equity?
Total Equity
165.4B
KRW
Based on the financial report for Dec 31, 2025, Ahn-Gook Pharmaceutical Co Ltd's Total Equity amounts to 165.4B KRW.
What is Ahn-Gook Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
2%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Ahn-Gook Pharmaceutical Co Ltd have been 2% over the past three years , 3% over the past five years , and 2% over the past ten years .
